SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-290613
Filing Date
2019-11-13
Accepted
2019-11-13 09:03:02
Documents
3
Period of Report
2019-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d821050d8k.htm 8-K 16243
2 EX-99.1 d821050dex991.htm EX-99.1 41644
3 GRAPHIC g821050g76o50.jpg GRAPHIC 6906
  Complete submission text file 0001193125-19-290613.txt   68881
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 191211851
SIC: 2834 Pharmaceutical Preparations